184 related articles for article (PubMed ID: 30848689)
41. Retinoic acid attenuates cytokine-driven fibroblast degradation of extracellular matrix in three-dimensional culture.
Zhu YK; Liu X; Ertl RF; Kohyama T; Wen FQ; Wang H; Spurzem JR; Romberger DJ; Rennard SI
Am J Respir Cell Mol Biol; 2001 Nov; 25(5):620-7. PubMed ID: 11713105
[TBL] [Abstract][Full Text] [Related]
42. TNF-alpha and IL-1beta-mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells.
Nee LE; McMorrow T; Campbell E; Slattery C; Ryan MP
Kidney Int; 2004 Oct; 66(4):1376-86. PubMed ID: 15458430
[TBL] [Abstract][Full Text] [Related]
43. Interleukin-1beta regulates cell proliferation and activity of extracellular matrix remodelling enzymes in cultured primary pig heart cells.
Zitta K; Brandt B; Wuensch A; Meybohm P; Bein B; Steinfath M; Scholz J; Albrecht M
Biochem Biophys Res Commun; 2010 Sep; 399(4):542-7. PubMed ID: 20678474
[TBL] [Abstract][Full Text] [Related]
44. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
[TBL] [Abstract][Full Text] [Related]
45. Cytokine endpoints for the local lymph node assay: consideration of interferon-gamma and interleukin 12.
Dearman RJ; Hilton J; Basketter DA; Kimber I
J Appl Toxicol; 1999; 19(3):149-55. PubMed ID: 10362264
[TBL] [Abstract][Full Text] [Related]
46. Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways.
Eberhardt W; Huwiler A; Beck KF; Walpen S; Pfeilschifter J
J Immunol; 2000 Nov; 165(10):5788-97. PubMed ID: 11067938
[TBL] [Abstract][Full Text] [Related]
47. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer.
Tahara H; Lotze MT
Gene Ther; 1995 Mar; 2(2):96-106. PubMed ID: 7719935
[TBL] [Abstract][Full Text] [Related]
48. An IL-12/Shh-C domain fusion protein-based IL-12 autocrine loop for sustained natural killer cell activation.
Zhu L; Zhao Z; Wei Y; Marcotte W; Wagner TE; Yu X
Int J Oncol; 2012 Aug; 41(2):661-9. PubMed ID: 22581115
[TBL] [Abstract][Full Text] [Related]
49. Neonatal exposure to a self-peptide-immunoglobulin chimera circumvents the use of adjuvant and confers resistance to autoimmune disease by a novel mechanism involving interleukin 4 lymph node deviation and interferon gamma-mediated splenic anergy.
Min B; Legge KL; Pack C; Zaghouani H
J Exp Med; 1998 Dec; 188(11):2007-17. PubMed ID: 9841915
[TBL] [Abstract][Full Text] [Related]
50. TNF enhances CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease by IL-12-independent mechanisms.
Brown GR; Lee EL; Thiele DL
J Immunol; 2003 May; 170(10):5082-8. PubMed ID: 12734353
[TBL] [Abstract][Full Text] [Related]
51. Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination.
Tan C; Dannull J; Nair SK; Ding E; Tyler DS; Pruitt SK; Lee WT
J Surg Res; 2013 Dec; 185(2):904-11. PubMed ID: 23891424
[TBL] [Abstract][Full Text] [Related]
52. IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNF alpha blockage and modulation by IL-10.
Nold M; Goede A; Eberhardt W; Pfeilschifter J; Mühl H
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):68-75. PubMed ID: 12616343
[TBL] [Abstract][Full Text] [Related]
53. Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta: a role for the dual signalling pathways, Akt and Erk.
Ruhul Amin AR; Senga T; Oo ML; Thant AA; Hamaguchi M
Genes Cells; 2003 Jun; 8(6):515-23. PubMed ID: 12786942
[TBL] [Abstract][Full Text] [Related]
54. A recombinant anti-erbB2, scFv-Fc-IL-2 fusion protein retains antigen specificity and cytokine function.
Shi M; Xie Z; Feng J; Sun Y; Yu M; Shen B; Guo N
Biotechnol Lett; 2003 May; 25(10):815-9. PubMed ID: 12882013
[TBL] [Abstract][Full Text] [Related]
55. Regulation of cytokine production in aging: use of recombinant cytokines to upregulate mitogen-stimulated spleen cells.
Frasca D; Pucci S; Goso C; Barattini P; Barile S; Pioli C; Doria G
Mech Ageing Dev; 1997 Feb; 93(1-3):157-69. PubMed ID: 9089580
[TBL] [Abstract][Full Text] [Related]
56. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production.
Micallef MJ; Ohtsuki T; Kohno K; Tanabe F; Ushio S; Namba M; Tanimoto T; Torigoe K; Fujii M; Ikeda M; Fukuda S; Kurimoto M
Eur J Immunol; 1996 Jul; 26(7):1647-51. PubMed ID: 8766574
[TBL] [Abstract][Full Text] [Related]
57. Anti-CD30-scFv-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells.
Heuser C; Guhlke S; Matthies A; Bender H; Barth S; Diehl V; Abken H; Hombach A
Int J Cancer; 2004 Jun; 110(3):386-94. PubMed ID: 15095304
[TBL] [Abstract][Full Text] [Related]
58. High expression of fusion proteins consisting of a single-chain variable fragment antibody against a tumor-associated antigen and interleukin-2 in Escherichia coli.
Napathorn SC; Kuroki M; Kuroki M
Anticancer Res; 2014 Aug; 34(8):3937-46. PubMed ID: 25075015
[TBL] [Abstract][Full Text] [Related]
59. Tetraspecific scFv construct provides NK cell mediated ADCC and self-sustaining stimuli via insertion of IL-15 as a cross-linker.
Schmohl JU; Felices M; Todhunter D; Taras E; Miller JS; Vallera DA
Oncotarget; 2016 Nov; 7(45):73830-73844. PubMed ID: 27650544
[TBL] [Abstract][Full Text] [Related]
60. Tumor-fibroblast interactions stimulate tumor vascularization by enhancing cytokine-driven production of MMP9 by tumor cells.
Limoge M; Safina A; Beattie A; Kapus L; Truskinovsky AM; Bakin AV
Oncotarget; 2017 May; 8(22):35592-35608. PubMed ID: 28423685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
